These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6398580)

  • 1. Propionibacterium, Corynebacterium, Mycobacterium and Lepra bacilli.
    Barksdale L; Kim KS
    Acta Leprol; 1984; 2(2-4):153-74. PubMed ID: 6398580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical studies with leprosy-derived corynebacteria.
    Cocito C; Abou-Zeid C; Danhaive P; Fontaine F; Gailly C; Gueur MC; Janczura E; Delville J
    Acta Leprol; 1982; (88):33-46. PubMed ID: 6818817
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphologic and biologic properties of diphtherroid organisms (LDC) isolated in leprosy].
    Delville J; Spina A; Rayyan W; Cocito C; Saint-André P; Niamien N'Deli L; Van Droogenbroeck J
    Acta Leprol; 1982; (86-87):59-68. PubMed ID: 6815998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation in leprosy-associated bacteria: Mycobacterium leprae and Corynebacterium tuberculostearicum.
    Hottat F; Coene M; Cocito C
    Med Microbiol Immunol; 1988; 177(1):33-45. PubMed ID: 2828900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of antigen BCG 60 in leprosy derived corynebacteria and other coryneforms.
    Papa FP; Rauzier JY; David HL
    Acta Leprol; 1984; 2(2-4):351-8. PubMed ID: 6398594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Propionibacterium acnes treatment on the course of Mycobacterium leprae infection in mice.
    Krahenbuhl JL; Humphres RC; Henika PC
    Infect Immun; 1982 Jul; 37(1):183-8. PubMed ID: 7049949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological properties of diphtheroïd bacteria (LDC) isolated from human leprosy lesions.
    Delville J; de Sloovère T; Fontaine F; Gueur MC; Rajjan W; Spina A; Cocito C
    Acta Leprol; 1982; (88):47-59. PubMed ID: 6818818
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphoproliferative responses of leprosy patients and healthy controls to nitrocellulose-bound M. leprae antigens.
    Sachdeva G; Kaur G; Bhutani LK; Bamezai RN
    Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):133-42. PubMed ID: 10472365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crossreactivity between Mycobacterium leprae and various actinomycetes and related organisms.
    Ridell M
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):185-90. PubMed ID: 6352526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Protective properties of M. lufu in experimental leprosy].
    Iushin MIu; Kalianina OV
    Probl Tuberk; 1995; (2):47-8. PubMed ID: 7777465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
    Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
    Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the suppression of the immune response in pre-clinical lepromatous leprosy affect both cell-mediated and humoral responses in Mycobacterium leprae antigens?
    Stoner GL
    Lepr Rev; 1981 Mar; 52(1):102-3. PubMed ID: 7017316
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of skin tests with five different mycobacteria.
    Girdhar BK; Desikan KV
    Lepr India; 1978 Oct; 50(4):555-9. PubMed ID: 374873
    [No Abstract]   [Full Text] [Related]  

  • 15. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative characteristics of antigenic profile of M. leprae and M. lufu.
    Salamatina OS; Dyachina MN; Juscenko AA; Parshin MP; Chernoyusova LN
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):39-43. PubMed ID: 11480317
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Mycobacterium leprae on lymphocyte proliferation: suppression of mitogen and antigen responses of human peripheral blood mononuclear cells.
    Touw J; Stoner GL; Belehu A
    Clin Exp Immunol; 1980 Sep; 41(3):397-405. PubMed ID: 6449337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lepra reactions.
    Godal T
    Ethiop Med J; 1973 Apr; 11(2):194-5. PubMed ID: 4596877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.